VIEW
IN BROWSER
EDITOR'S
NOTE: Big4Bio newsletters will not be published
from Dec 16, 2025, to Jan 4, 2026; they will
resume distribution on Monday, Jan 5, 2026.
|
 |
| DECEMBER
12, 2025 |
|
Covering Life Sciences Drugs, Diagnostics,
Devices, Digital Health |
|
|
|
* may need subscription to view |
- Amgen: FDA Approves Uplizna for
Adults With Generalized Myasthenia Gravis More
More*
- Cedars-Sinai: Strengthens AI Foundation,
Accelerates Momentum More
- eXoZymes: Achieves 100× Scale-up of NCT
Production Using Exozymes, Demonstrating
Near-perfect Feedstock Conversion More
- ImmunityBio: Receives Conditional Marketing
Authorization Recommendation From the European
Medicines Agency for ANKTIVA With BCG for
Non-Muscle Invasive Bladder Cancer Carcinoma
in Situ—A First in Europe More
- Ruthless Spine: Gad Medical Ltd.
Receives Regulatory Approval to Start Sales
of RJB Interoperative Angle Measurement
Instrument in Israel, Marking Significant
Expansion Following NASS Momentum More
- USC: Researchers Develop
Next-Generation CAR T Cells That Show
Stronger, Safer Response in Animal Models More
|
|
- JPM Week Conference Readiness
Packages (Big4Bio Subscriber Discount) More
- STAAR Surgical: Sets the Record Straight
Regarding Its Robust Go-Shop Process More
|
|
- Amgen
Obesity Marketing Leader Chris Boulton Takes
Reins at Metabolic Biotech Prolynx More
- BioPharmGuy News: Pre-Holiday Roast, New Flu
Dropped, Purdue Tumbles, High Energy Decision
More
- Subscribe to LifeSci Startup for
Updates on US Startups More
- The Big4Bio Podcast: Every Moment
Matters: Integrating AI into Drug Discovery
Podcast
|
|
|
DISCOVER COMPANIES |
|
Big4Bio: Los Angeles Life Science
Company Directory |
|
Locate a specific company or
explore new companies in life
science. |
|
Explore
our Company Directory
|
Provided courtesy
of
 |
|
|
|
Feature your company |
|
Apply to have your company
showcased
by Big4Bio. |
|
|
|
|
|
 |
| Organizational
Leader and Business Strategist
Kyle Kinzie Named President &
Partner |
|
Learn More
→ |
|
|
- Feature: M&A in Life Sciences:
The Turning Tide – Why Now is a Strategic
Inflection for Biopharma and Biotech More
- ICYMI: The Rise of Fractional Talent in Life
Sciences: What to Expect in 2026 More
- ICYMI: Elevating Executive Presence: A
Blueprint for Life Sciences and Biotech
Leaders More
- ICYMI: CEO's Perspective: Big Moves Come
with Big Responsibility More
- ICYMI: CEO's Perspective: The High Cost of
Job Hopping More
- ICYMI: The Power of Peer Learning: Why Even
Top Biotech Leaders Need Mentorship More
- ICYMI: What's Next in Precision Medicine:
Leadership Challenges and Opportunities More
|
|
 |
|
|
|
You are
receiving this email because
you signed up for one of our
newsletters at Big4Bio.com,
signed up at one of our
partner or sponsor events,
or given as a gift
subscription by your firm or
organization. Unsubscribe
Big4Bio:Los
Angeles, all rights reserved
2025
© 2025
Big4Bio, a division of
BigBio Communications. All
rights reserved.
|
|
|
|
|
